Financial Markets

Financial Markets

Public and private markets, financial instruments, stocks, crypto, earnings reports, and market analysis.

markets

SEC proposes to rescind 2024 climate-disclosure rule

The SEC proposed formally rescinding its 2024 climate-disclosure rule, opening a 60-day comment period and seeking to erase the standardized climate-reporting framework.

#sec, #climate, #disclosure, #regulation

markets

CFTC Staff Says Some Deribit Perpetuals Can Be Treated as Foreign Futures; Coinbase Subsidiary Gets Conditional No-Action Relief

CFTC staff says Deribit perpetuals may qualify as foreign futures and grants Coinbase Financial Markets conditional relief to post customer crypto as margin.

$COIN, #cftc, #coinbase, #crypto, #deribit

markets

Costco Reports Strong Q3 Results, Sales Up 11.6% as Digital Growth Surges

Costco posted fiscal Q3 net sales of $69.154B and net income of $2.192B; digitally enabled sales jumped 21.5% and membership fees reached $1.373B.

$COST, #costco, #earnings, #retail, #stocks

markets

4,180 BTC ($304.7M) Transferred From Addresses Labeled 'Coinbase Institutional' to New Wallet

Blockchain tracker Whale Alert flagged a May 28 transfer of 4,180 BTC (about $304.7M) from addresses labeled 'Coinbase Institutional' to a new unknown wallet.

$COIN, #bitcoin, #coinbase, #cryptocurrency, #whalealert

markets

About $1.3 Billion Dark-Pool Block of BlackRock’s IBIT Traded as Bitcoin Fell

A roughly $1.3bn dark-pool block of BlackRock’s IBIT changed hands May 26 as Bitcoin dipped and U.S. spot ETFs saw net outflows.

$IBIT, $BLK, #bitcoin, #etf, #blackrock, #darkpool

markets

SpaceX Files for IPO, Revealing Starlink Profits, xAI Losses and a Super‑Voting Plan to Keep Musk in Control

SpaceX filed for an IPO, disclosing $18.7B revenue for 2025, profitable Starlink, heavy xAI losses and a super‑voting share plan to keep Musk in control.

#spacex, #ipo, #starlink, #xai, #elonmusk

markets

SEC Proposes Major Rewrite of Registered Offerings and Public-Company Reporting

SEC proposes broad overhaul of registered offerings and filer categories to ease capital raising and expand scaled reporting relief for smaller issuers.

#sec, #securities, #regulation, #ipos

markets

SEC Rescinds Decades-Old 'No-Deny' Settlement Policy and Will Not Enforce Past Provisions

The SEC removed Rule 202.5(e), ending decades of 'no-deny' settlement provisions and saying it will not enforce existing no‑deny clauses.

#sec, #securities, #regulation, #enforcement

markets

UK’s FCA and Bank of England set roadmap for tokenisation and longer settlement hours

FCA and Bank of England launch joint consultation on tokenised securities, outline RTGS sync service for 2028 and staged steps toward near-24/7 settlement.

#tokenisation, #bankofengland, #fca, #settlement

markets

How a KelpDAO rsETH Exploit Knocked Aave From the Top of DeFi TVL Rankings

An April rsETH exploit routed stolen tokens into Aave, triggering risk controls and a 44% drop in Aave's TVL as Lido reclaimed the top spot.

#defi, #aave, #lido, #layerzero

markets

Creditors Ask New York Court to Force Tether to Turn Over $344M in Frozen USDT

Creditors with terrorism judgments ask a New York court to compel Tether to cancel and reissue $344.1m in frozen USDT tied to Iran sanctions.

#tether, #usdt, #iran, #sanctions, #cryptocurrency

markets

Hub Group Expands Scope of Accounting Problems, Says 2023 and 2024 Audited Statements 'Should No Longer Be Relied On'

Hub Group's audit committee says audited financial statements for 2023 and 2024 were materially misstated and should not be relied on.

$HUBG, #hubgroup, #accounting, #restatement, #sec, #nasdaq

markets

SEC Proposes Letting Public Companies File Semiannual 10-S Instead of Quarterly 10-Qs

The SEC proposed letting U.S. public companies swap quarterly 10-Qs for a single semiannual 10-S, aiming to reduce filings while preserving 8-K disclosures.

#sec, #disclosure, #filings, #regulation

markets

Pfizer Keeps 2026 Outlook as Q1 Revenue Rises 5%; COVID Sales Slide

Pfizer posted 5% revenue growth in Q1 and kept its 2026 outlook, as gains from newer drugs offset steep declines in Comirnaty and Paxlovid sales.

$PFE, #pfizer, #earnings, #pharma

markets

Cerebras Sets Terms for Revived IPO That Could Raise Up to $3.5 Billion

Sunnyvale AI-chip maker plans to sell 28m shares at $115–$125 for a Nasdaq CBRS listing; implied valuation about $26.6B with concentrated customers.

$CBRS, #ai, #ipo, #semiconductors, #cerebras